Literature DB >> 19179901

Defining genomic alteration boundaries for a combined small cell and non-small cell lung carcinoma.

Timon P H Buys1, Sarit Aviel-Ronen, Thomas K Waddell, Wan L Lam, Ming-Sound Tsao.   

Abstract

In the rare case of a male patient presenting with a combined small cell lung carcinoma (SCLC), large cell neuroendocrine carcinoma and adenocarcinoma, we used whole genome analysis by tiling-path array comparative genomic hybridization to evaluate the clonal relationship between nodules. In two areas of SCLC distinguishable by divergent neuroendocrine marker expression (CD56 and chromogranin-A), the presence of identical genomic breakpoints and rearrangements indicated a common origin, with the presence of additional distinct genomic alterations in these two components indicating diverging clonal evolution. The absence of shared genome alteration features for the adenocarcinoma and large cell neuroendocrine carcinoma components suggested that these tumors evolved independently from the SCLC. Taken together, the array comparative genomic hybridization data demonstrate the development and evolution of three independent primary lung cancers in close proximity to each other to form a combined carcinoma. Application of whole genome analysis shows the potential utility of high resolution molecular tools in resolving the origin and delineating the clonal relationships of a tumor that contains heterogeneous histologic components leading to an ambiguous histogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19179901     DOI: 10.1097/JTO.0b013e3181952678

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  9 in total

1.  A dynamic oral cancer field: unraveling the underlying biology and its clinical implication.

Authors:  Ivy F L Tsui; Cathie Garnis; Catherine F Poh
Journal:  Am J Surg Pathol       Date:  2009-11       Impact factor: 6.394

2.  Combined Small Cell Carcinoma of the Lung: Is It a Single Entity?

Authors:  Xiaoliang Zhao; Justine N McCutcheon; Bhaskar Kallakury; Joeffrey J Chahine; Drew Pratt; Mark Raffeld; Yulong Chen; Changli Wang; Giuseppe Giaccone
Journal:  J Thorac Oncol       Date:  2017-10-31       Impact factor: 15.609

Review 3.  Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.

Authors:  Raj Chari; Kelsie L Thu; Ian M Wilson; William W Lockwood; Kim M Lonergan; Bradley P Coe; Chad A Malloff; Adi F Gazdar; Stephen Lam; Cathie Garnis; Calum E MacAulay; Carlos E Alvarez; Wan L Lam
Journal:  Cancer Metastasis Rev       Date:  2010-03       Impact factor: 9.264

4.  Paclitaxel-etoposide-carboplatin/cisplatin versus etoposide-carboplatin/cisplatin as first-line treatment for combined small-cell lung cancer: a retrospective analysis of 62 cases.

Authors:  Yue-Ya Li; Chan Zhou; Deng-Xia Yang; Jing Wang; Zhu-Jun Liu; Xin-Yue Wang; Kai Li
Journal:  Cancer Biol Med       Date:  2015-06       Impact factor: 4.248

5.  Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.

Authors:  Rebecca Towle; Ivy F L Tsui; Yuqi Zhu; Sara MacLellan; Catherine F Poh; Cathie Garnis
Journal:  Cancer Med       Date:  2014-07-24       Impact factor: 4.452

6.  Comprehensive genomic profiling of combined small cell lung cancer.

Authors:  Jing Zhang; Liping Zhang; Jie Luo; Tao Ge; Pengyu Fan; Liangdong Sun; Likun Hou; Junqiang Li; Huansha Yu; Chunxiao Wu; Yuming Zhu; Chunyan Wu; Gening Jiang; Giancarlo Troncone; Jyoti Malhotra; Katsuhiro Okuda; Mariacarmela Santarpia; Rita Zamarchi; Taichiro Goto; Andrés F Cardona; Jianfang Xu; Qiankun Chen; Zhonghong Zhang; Peng Zhang
Journal:  Transl Lung Cancer Res       Date:  2021-02

7.  In-depth molecular analysis of combined and co-primary pulmonary large cell neuroendocrine carcinoma and adenocarcinoma.

Authors:  Bregtje C M Hermans; Jules L Derks; Lisa M Hillen; Irene van der Baan; Esther C van den Broek; Jan H von der Thüsen; Robert-Jan van Suylen; Peggy N Atmodimedjo; T Dorine den Toom; Cecile Coumans-Stallinga; Wim Timens; Winand N M Dinjens; Hendrikus J Dubbink; Ernst-Jan M Speel; Anne-Marie C Dingemans
Journal:  Int J Cancer       Date:  2021-11-10       Impact factor: 7.316

8.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

9.  Applying unmixing to gene expression data for tumor phylogeny inference.

Authors:  Russell Schwartz; Stanley E Shackney
Journal:  BMC Bioinformatics       Date:  2010-01-20       Impact factor: 3.169

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.